人淋巴瘤细胞JVM-13
BLUEFBIO™ Product Sheet
细胞名称 |
人淋巴瘤细胞JVM-13 |
||
货物编码 |
BFN60811437 |
||
产品规格 |
T25培养瓶x1 |
1.5ml冻存管x2 |
|
细胞数量 |
1x10^6 |
1x10^6 |
|
保存温度 |
37℃ |
-198℃ |
|
运输方式 |
常温保温运输 |
干冰运输 |
|
安全等级 |
1 |
||
用途限制 |
仅供科研 3类 |
培养体系 |
DMEM(HYCLONE SH30022.01)+10%FBS+1%三抗 |
||
培养温度 |
37℃ |
二氧化碳浓度 |
5% |
简介 |
人淋巴瘤细胞JVM-13取自60岁男性供体,该细胞保藏于ATCC |
||
注释 |
Part of: LL-100 blood cancer cell line panel. Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank). Part of: MD Anderson Cell Lines Project. Doubling time: 58 hours (PubMed=25315077); ~70 hours (DSMZ). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood. |
||
基因突变 |
|
||
HLA信息 |
Class I HLA-A A*03:01,02:01 HLA-B B*56:01,15:01 HLA-C C*01:02,03:03 Class II HLA-DQ DQA1*01:03,01:03 DQB1*06:03,06:03 HLA-DR DRB1*13:01,03:38
|
||
STR信息 |
Amelogenin X,Y CSF1PO 10,12 D5S818 11 D7S820 9 D13S317 9,11 D16S539 11 TH01 6,7 TPOX 10,11 vWA 16,18 |
||
参考文献 |
PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005 Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H. Characterization of human cancer cell lines by reverse-phase protein arrays. Cancer Cell 31:225-239(2017) PubMed=29666304; DOI=10.1158/1078-0432.CCR-17-3004 Pham L.V., Huang S.-J., Zhang H., Zhang J., Bell T., Zhou S., Pogue E., Ding Z., Lam L., Westin J., Davis R.E., Young K.H., Medeiros L.J., Ford R.J., Nomie K., Zhang L., Wang M. Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas. Clin. Cancer Res. 24:3967-3980(2018) PubMed=31160637; DOI=10.1038/s41598-019-44491-x Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K., Uphoff C.C., Drexler H.G. The LL-100 panel: 100 cell lines for blood cancer studies. Sci. Rep. 9:8218-8218(2019) |